Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.7 USD | -2.47% | -4.83% | -40.29% |
May. 15 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
May. 14 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
Financials (USD)
Sales 2024 * | 63.08M | Sales 2025 * | 66.72M | Capitalization | 183M |
---|---|---|---|---|---|
Net income 2024 * | 11M | Net income 2025 * | 16M | EV / Sales 2024 * | 2.9 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.74 x |
P/E ratio 2024 * |
16.3
x | P/E ratio 2025 * |
11.4
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.16% |
Latest transcript on Fennec Pharmaceuticals Inc.
1 day | -2.47% | ||
1 week | -4.83% | ||
Current month | -27.02% | ||
1 month | -27.25% | ||
3 months | -26.70% | ||
6 months | -24.21% | ||
Current year | -40.29% |
Managers | Title | Age | Since |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 09-07-06 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 09-07-06 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 14-04-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 11-08-24 |
Khalid Islam
CHM | Chairman | 67 | 14-04-24 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 09-07-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +4.20% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 6.7 | -2.47% | 134,319 |
24-05-23 | 6.87 | -4.45% | 80,425 |
24-05-22 | 7.19 | +0.98% | 153,643 |
24-05-21 | 7.12 | -2.60% | 114,526 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.29% | 183M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-0.29% | 21.78B | |
-9.28% | 18.09B | |
-41.70% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- FENC Stock